Risk factors for sexual dysfunction among Chinese women with type 2 diabetes

Sexual dysfunction in women with breast cancer of Northeast Brazil: a retrospective longitudinal study

Breast cancer treatment leads to physical and psychological changes. The aim of this study was to analyze the incidence of sexual dysfunction and its risk factors in women diagnosed with breast cancer. This retrospective cohort study included women diagnosed and treated for breast cancer (exposed group, n = 90) and healthy women (non-exposed group, n = 93). Data were collected from February 2019 to October 2021 in the state of Rio Grande do Norte (Northeast Brazil), from medical records and using the Female Sexual Function Index (FSFI) questionnaire. Data were collected from medical records and using the Female Sexual Function Index (FSFI) questionnaire. Primary outcomes were analyzed using binary logistic regression. The Mann-Whitney test was used to analyze FSFI domains between groups. The exposed group had a 74% incidence of sexual dysfunction and 3.9 times increased chances of having sexual dysfunction compared with the non-exposed group (OR 3.9, CI 1.8 to 8.2, p < 0.001). Presence of comorbidities increased the chances of sexual dysfunction by 2.5 times (OR 2.5, CI 1.2 to 4.9, p = 0.009). Women diagnosed and treated for breast cancer had a higher incidence of sexual dysfunction than healthy women. Furthermore, comorbidities also increased the chances of sexual dysfunction regardless of exposure to breast cancer.

Prevalence and associated factors of female sexual dysfunction among type 2 diabetes patients in Indonesia: A systematic review and meta-analysis

BACKGROUND AND AIMS

Female sexual dysfunction (FSD) is a neglected chronic complication of diabetes. However, there is a scarcity of data in Indonesia, which is currently ranked as the 5th in the world for the number of people with Type 2 Diabetes (T2D). Our study aims to analyze the prevalence and factors of FSD among T2D patients in Indonesia.

METHOD

Literature searching was performed in PubMed/Medline®, CINAHL®, Embase®, Proquest®, Scopus®, local journals and libraries. All studies in searching keywords "sexual", "diabetes" and "Indonesia" with Medical Subject Headings (MeSH) terms were included, without time or language restriction. Pooled prevalence and odds ratio of associated factors of FSD were analyzed using STATA.

RESULTS

Ten studies comprised 572 females with T2D were included in this review. The pooled prevalence of FSD reached 52% (95% CI = 0.49-0.56; I2 93.9%, p < 0.001). After removing one study that was conducted with an unstandardized questionnaire cut-off value, the pooled prevalence of FSD was 62% (95% CI = 0.58-0.66; I2 68.7%, p = 0.001). Age more than 45 years old and or menopause, and the use of antihypertensives were associated with FSD. While Hemoglobin A1c (HbA1c) is only correlated with a desire for sexual dysfunction.

CONCLUSION

FSD was prevalent among T2D patients in Indonesia and was associated with age more than 45 years old, menopause, and the use of antihypertensive medications.

[The importance of biomedical indicators in sexual functioning in healthy Portuguese adults]

BACKGROUND

The aim of this study was to investigate the influence of biomedical indicators, such as body mass index, blood glucose, total cholesterol, triglycerides, systolic blood pressure and diastolic blood pressure, on sexual functioning in Portuguese adults.

METHODS

The sample consisted of 225 healthy individuals (non-smokers, women not taking contraceptive pill), aged 18-89 years (mean = 41 years), of whom 107 were males and 117 females. A Sociodemographic Questionnaire, the Portuguese version of the Massachusetts General Hospital Sexual Functioning Questionnaire (MGH-SFQ) and biomedical indicators measurement devices were applied.

RESULTS

59.6% (N = 134) of the participants presented levels for global sexual functioning below the expected values. Men scored better overall sexual functioning when compared to women, as well as the group of younger participants. Significant correlational values between BMI (r = -253, p <.001), glycemic index (r = -.230, p <.001), total cholesterol (r = -144, p < .05) and sexual functioning were obtained. The hierarchical regression model allowed to demonstrate the mediating effect of the biomedical variables on sexual functioning, explaining 31% (r2 = .31; p <.001) of the total variance.

DISCUSSION AND CONCLUSIONS

This research makes it possible to highlight the importance of biomedical indicators in sexual functioning, helping professionals working in this area to be aware of how biomedical contexts interfere with sexual expression.